Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Bone Marrow Transplantation|November 2, 2004
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosisR Saccardi, A Tyndall, G Coghlan, et al.
Annals of the Rheumatic Diseases|August 14, 2009
The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategyM Matucci-Cerinic, Y Allanore, L Czirják, et al.
Annals of the Rheumatic Diseases|November 20, 2004
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseasesJ-E Gottenberg, L Guillevin, O Lambotte, et al.
Journal De Medecine Vasculaire|February 15, 2020
Management of cancer-related thrombosis in the era of direct oral anticoagulants: A comprehensive review of the 2019 ITAC-CME clinical practice guidelines. On behalf of the Groupe Francophone Thrombose et Cancer (GFTC)H Rafii, C Frère, I Benzidia, et al.
Bone Marrow Transplantation|January 14, 2009
Allogeneic hematopoietic SCT for patients with autoimmune diseasesT Daikeler, T Hügle, D Farge, et al.
Scandinavian Journal of Rheumatology|July 25, 2018
Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) databaseP E Carreira, L Carmona, B E Joven, et al.
Bone Marrow Transplantation|March 15, 2005
Autologous hematopoietic stem cell transplantation for autoimmune diseasesA Gratwohl, J Passweg, C Bocelli-Tyndall, et al.
Annals of the Rheumatic Diseases|May 29, 2007
Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosisM C Vonk, Z Marjanovic, F H J van den Hoogen, et al.
Annals of the Rheumatic Diseases|July 26, 2011
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centresJ Fransen, D Popa-Diaconu, R Hesselstrand, et al.
Annals of the Rheumatic Diseases|January 17, 2009
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)O Kowal-Bielecka, R Landewé, J Avouac, et al.
Pageof 17